Analytical Data
-
Gene name
SELENBP1
- Application
-
Alternative Names
LPSB; SP56; hSBP; hSP56; SBP56; 56 kDa selenium-binding protein
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q13228
-
Expression Region
Thr46~Ser286
-
Molecular Weight
28kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SELENBP1, or selenium-binding protein 1, has garnered considerable attention in recent years due to its potential roles in various biological processes and disease states. This protein is known to be involved in selenium metabolism and has been implicated in antioxidant defense mechanisms, cell proliferation, and apoptosis. Research has demonstrated that SELENBP1 may play a critical role in cancer biology, with varying expressions observed across different tumor types, suggesting its potential as a biomarker for cancer diagnosis and prognosis. Moreover, SELENBP1's involvement in the regulation of cellular responses to oxidative stress also links it to various neurodegenerative diseases, highlighting its significance in maintaining cellular homeostasis. The production of recombinant SELENBP1 is crucial for elucidating its structural properties and functional mechanisms. By obtaining a pure form of this protein through recombinant DNA technology, researchers can perform in-depth studies to understand its interactions and biological activities. This foundational research is essential for exploring therapeutic applications, particularly in targeting SELENBP1's pathways in cancer treatment and neuroprotection. Overall, the study of recombinant SELENBP1 represents a promising avenue for advancing our understanding of selenium-related biology and its implications in health and disease.
